The present invention relates to a pharmaceutical combination comprising a first active ingredient which is N-[1-(5-Cyano-pyridin-2-ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-acetamide or a pharmaceutically acceptable salt thereof and a second active ingredient which has an anti-epileptic effect, or a pharmaceutically acceptable salt thereof.本發明係關於一種醫藥組合,其包含:第一活性成分,該第一活性成分為N-[1-(5-氰基-吡啶-2-基甲基)-1H-吡唑-3-基]-2-[4-(1-三氟甲基-環丙基)-苯基]-乙醯胺或其醫藥學上可接受之鹽;及具有抗癲癇效果之第二活性成分或其醫藥學上可接受之鹽。